We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 9,467

DFARS: Safeguarding Covered Defense Information and Cyber Incident Reporting
  • Reed Smith LLP
  • USA
  • March 23 2017

Data protection and cybersecurity have been receiving ever-increasing attention within the U.S. federal government. Last October, the DoD issued two


Disputed Federal Regulatory Duty Allows Federal Question Removal
  • Reed Smith LLP
  • USA
  • March 23 2017

As we’ve mentioned before, we watch state-law litigation over genetically-modified organisms (“GMOs”) because they tend to produce interesting


Warning: Lawyers May Be Hazardous To Your Health
  • Reed Smith LLP
  • USA
  • March 22 2017

Most of the cases we defend involve claims of inadequate warnings. What makes a warning inadequate? Falsehood is the first thing that comes to mind


And Then There Were Two - New Mexico Set to Become 48th State to Enact Data Breach Notification Law
  • Reed Smith LLP
  • USA
  • March 21 2017

While there is no federal law requiring companies to notify individuals of data breaches, South Dakota and Alabama will be the only states without


Congressional Panels Examining Pharmaceutical Distribution Systems, FDA Drug User Fees
  • Reed Smith LLP
  • USA
  • March 21 2017

Two Congressional committees are holding hearings this week on FDA user fees: a March 21 Senate Health, Education, Labor, and Pensions Committee


All Things “Considered”: Plaintiffs’ Experts Ordered To Produce Patient Records
  • Reed Smith LLP
  • USA
  • March 21 2017

“The facts and data considered by the witness . . . .” That is what expert witnesses must disclose to the other side after forming their opinions


What If We Win? Off-Label Promotion & Product Liability
  • Reed Smith LLP
  • USA
  • March 20 2017

Since the nomination of Dr. Scott Gottlieb to head the FDA, we’ve seen quite a few references to his opposition to the current FDA prohibition


For Media Transparency, The Stars Are Starting to Align in the United Kingdom
  • Reed Smith LLP
  • United Kingdom, USA
  • March 20 2017

UK-based media agency, the7stars, recently announced it would adopt the Incorporated Society of British Advertisers’ (ISBA) template agency


340B Ceiling PriceCMP Rule Effective Date Pushed Back to May 22, 2017 “At the Earliest”
  • Reed Smith LLP
  • USA
  • March 17 2017

The Health Resources and Services Administration (HRSA) is delaying the effective date of its January 5, 2017 final rule on the calculation of the


Another Court Tackles Prescription Drug Design Defect
  • Reed Smith LLP
  • USA
  • March 17 2017

If you have been following along for a while, then you have surely run across our posts making some combination of the following points: 1) design